Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment
Sophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
Frontiers in Oncology
|
February 16, 2026
PSMA-guided management of recurrent post-prostatectomy patients: a sub-analysis of a prospective single-center study
Giuseppe Carlo Iorio, Cristiano Grossi, Valeria Chiofalo, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 19, 2019
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
Marie Terroir, Caroline Caramella, Isabelle Borget, et al.
Diagnostics (Basel, Switzerland)
|
September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy
Guido Rovera, Serena Grimaldi, Marco Oderda, et al.
European Radiology Experimental
|
June 14, 2022
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
Virginia Liberini, Riccardo Laudicella, Michele Balma, et al.
La Radiologia Medica
|
December 16, 2024
Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
Monica Finessi, Martina Cioffi, Serena Grimaldi, et al.
Inhalation Toxicology
|
May 9, 2008
Carbon monoxide levels experienced by heavy smokers impair aerobic capacity and cardiac contractility and induce pathological hypertrophy
Anja Bye, Sveinung Sørhaug, Marcello Ceci, et al.
European Urology
|
May 22, 2022
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Yohann Loriot, Matthieu Texier, Stéphane Culine, et al.
Frontiers in Oncology
|
September 15, 2022
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
Carla Rognoni, Maria Rosa Barcellona, Irene Bargellini, et al.
The Lancet. Gastroenterology & Hepatology
|
November 9, 2020
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
Etienne Garin, Lambros Tselikas, Boris Guiu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Thyroid : Official Journal of the American Thyroid Association
|
March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment
Sophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
Frontiers in Oncology
|
February 16, 2026
PSMA-guided management of recurrent post-prostatectomy patients: a sub-analysis of a prospective single-center study
Giuseppe Carlo Iorio, Cristiano Grossi, Valeria Chiofalo, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 19, 2019
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
Marie Terroir, Caroline Caramella, Isabelle Borget, et al.
Diagnostics (Basel, Switzerland)
|
September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy
Guido Rovera, Serena Grimaldi, Marco Oderda, et al.
European Radiology Experimental
|
June 14, 2022
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
Virginia Liberini, Riccardo Laudicella, Michele Balma, et al.
La Radiologia Medica
|
December 16, 2024
Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
Monica Finessi, Martina Cioffi, Serena Grimaldi, et al.
Inhalation Toxicology
|
May 9, 2008
Carbon monoxide levels experienced by heavy smokers impair aerobic capacity and cardiac contractility and induce pathological hypertrophy
Anja Bye, Sveinung Sørhaug, Marcello Ceci, et al.
European Urology
|
May 22, 2022
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Yohann Loriot, Matthieu Texier, Stéphane Culine, et al.
Frontiers in Oncology
|
September 15, 2022
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
Carla Rognoni, Maria Rosa Barcellona, Irene Bargellini, et al.
The Lancet. Gastroenterology & Hepatology
|
November 9, 2020
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
Etienne Garin, Lambros Tselikas, Boris Guiu, et al.
Page
of 5